参 考 文 献

　　1.Tolwani AJ，Wheeler TS，Wille KM.Sustained low-efficiency dialysis.Contrib Nephrol，2007，156：320-324

　　2.付平，张凌 .杂合肾脏替代治疗的临床应用 .中国血液净化，2011，10（1）：7-9

　　3.Schlaeper C，Amerling R，Manns M，et al.High clearance continuous renal replacement therapy with a modified dialysis machine.Kidney Int Suppl，1999，（72）：S20-S23

　　4.Davenport A.Renal replacement therapy in acute kidney injury：which method to use in the intensive care unit？Saudi J Kidney Dis Transpl，2008，19（4）：529-536

　　5.Kumar VA，Craig M，Depner TA，et al.Extended daily dialysis A new approach to renal replacement for acute renal failure in the intensive care unit.Am J Kidney Dis，2000，36（2）：294-300

　　6.Kielstein J，Kretschmer U，Ernst T，et al.Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients：a randomized controlled study.Am J Kidney Dis，2004，43（2）：342-349

　　7.Lonnemann G，Floege J，Kliem V，et al.Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system.Nephrol Dial Transplant，2000，15（8）：1189-1193

　　8.Shulman RI，Singer M，Rock J.Continuous renal replacement therapy.Keeping the circuit open：lessons from the lab.Blood Purif，2002，20（3）：275-281

　　9.Singer M，McNally T，Screaton G，et al.Heparin clearance during continuous veno-venous haenofiltration.Intensive Care Med，1994，20（3）：212-215

　　10.Tolwani AJ，Wille KM.Anticoagulation for continuous renal replacement therapy.Semin Dial，2009，22（2）：141-145

　　11.Binici DN，Gunes N.Risk factors leading to reduced bone mineral density in hemodialysis patients with metabolic syndrome.Ren Fail，2010，32（4）：469-474

　　12.Monchi M，Berghmans D，Ledoux D，et al.Citrate vs.heparin for anticoagulation in continuous venovenous hemofiltration：a prospective randomized study.Intensive Care Med，2004，30（2）：260-265

　　13.Hirsh J，Raschke R，Heparin and low-molecular-weight heparin：the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest，2004，126（3 Suppl）：188S-203S

　　14.Bagshaw SM，Laupland KB，Boiteau PJ，et al.Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy？A prospective observational study in an adult regional critical care system.J Crit Care，2005，20（2）：155-161

　　15.Oudemans-van Straaten HM，Wester JP，de Pont AC，et al.Anticoagulation strategies in continuous renal replacement therapy：can the choice be evidence based？Intensive Care Med，2006，32（2）：188-202

　　16.Brophy PD，Somers MJ，Baum MA，et al.Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy（CRRT）.Nephrol Dial Transplant，2005，20（7）：1416-1421

　　17.Abramson S，Niles JL.Anticoagulation in continuous renal replacement therapy.Curr Opin Nephro Hypertens，1999，8（6）：701-707

　　18.Keelum JA，Lameire N，Aspelin P，et al.KDIGO Clinical Practice Guideline for Acute Kidney Injury.Kidney Int Suppl，2012，2（1）：S1-S138

　　19.赵宇亮，张凌，付平.枸橼酸抗凝在肾脏替代治疗中的新进展.中华内科杂志，2012，51（7）：1-3

　　20.廖宇捷，张凌，付平 .连续性肾脏替代治疗抗凝剂的应用 .西部医学，2011，23（2）：389-391

　　21.Palsson R，Laliberte KA，Niles JL.Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.Clin Nephrol，2006，65（1）：34-42

　　22.Mehta RL，McDonald BR，Aguilar MM，et al.Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients.Kidney Int，1990，38（5）：976-981

　　23.Clark JA，Schulman G，Golper TA.Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.Clin J Am Soc Nephrol，2008，3（3）：736-742

　　24.Wu MY，Hsu YH，Bai CH，et al.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy：a meta-analysis of randomized controlled trials.Am J Kidney Dis，2012，59（6）：810-818

　　25.Oudemans-van Straaten HM，Kellum JA，Bellomo R.Clinical review：anticoagulation for continuous renal replacement therapy—heparin or citrate？Crit Care，2011，15（1）：202

　　26.Park J-S，Kim G-H，Kang CM，et al.Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration.Korean J Intern Med，2011，26（1）：68-75

　　27.Kutsogiannis DJ，Gibney RT，Stollery D，et al.Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.Kidney Int，2005，67（6）：2361-2367

　　28.O’Reilly P，Tolwani A.Renal replacement therapy Ⅲ：IHD，CRRT，SLED.Crit Care Clin，2005，21（2）：367-378

　　29.Conger J.Dialysis and related therapies.Semin Nephrol，1998，18（5）：533-540

　　30.Briglia A，Paganini EP.Acute renal failure in the intensive care unit.Therapy overview，patient risk stratification，complications of renal replacement，and special circumstances.Clin Chest Med，1999，20（2）：347-366

　　31.Emili S，Black NA，Paul RV，et al.A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients.Am J Kidney Dis，1999，33（6）：1107-1114

　　32.Marshall MR，Ma T，Galler D，et al.Sustained low-efficiency daily diafiltration（SLEDD-f）for critically ill patients requiring renal replacement therapy：towards an adequate therapy.Nephrol Dial Transplant，2004，19（4）：877-884

　　33.Alam M，Marshall M，Shaver M，et al.Cost comparison between sustained low efficiency hemodialysis（SLED）and continuous venovenous hemofiltration（CVVH）for ICU patients with ARF（abstract）.Am J Kidney Dis，2000，35：A9

　　34.Ma T，Walker R，Eggleton K，et al.Cost comparison between sustained low efficiency dialysis/diafiltration（SLEDD）and continuous renal replacement therapy for ICU patients with ARF（abstract）.Nephrology，2002，7：A54

　　35.Berbece A，Richardson R.Sustained low-efficiency dialysis in the ICU：cost，anticoagulation，and solute removal.Kidney Int，2006，70（5）：963-968

　　36.Kumar VA，Yeun JY，Depner TA，et al.Extended daily dialysis vs.continuous hemodialysis for ICU patients with acute renal failure：a two-year single center report.Int J Artif Organs，2004，27（5）：371-379

　　37.Marshall MR，Ma T，Galler D，et al.Sustained low-efficiency daily diafiltration（SLEDD-f）for critically ill patients requiring renal replacement therapy：towards an adequate therapy.Nephrol Dial Transplant，2004，19（4）：877-884

　　38.Holt BG，White JJ，Kuthiala A，et al.Sustained low-efficiency daily dialysis with hemofiltration for acute kidney injury in the presence of sepsis.Clin Nephrol，2008，69（1）：40-46

　　39.Salahudeen AK，Kumar V，Madan N，et al.Sustained low efficiency dialysis in the continuous mode（C-SLED）：dialysis efficacy，clinical outcomes，and survival predictors in critically ill cancer patients.Clin J Am Soc Nephrol，2009，4（8）：1338-1346

　　40.Ronco C，Brendolan A，Lonnemann G，et al.A pilot study of coupled plasma filtration with adsorption in septic shock.Crit Care Med，2002，30（6）：1250-1255

　　41.Tumlin J，Wali R，Williams W，et al.Efficacy and safety of renal tubule cell therapy for acute renal failure.J Am Soc Nephrol，2008，19（5）：1034-1040

　　42.Cruz DN，Antonelli M，Fumagalli R，et al.Early use of polymyxin B hemoperfusion in abdominal septic shock：the EUPHAS randomized controlled trial.JAMA，2009，301（23）：2445-2452

　　43.Wei Q，Baihai S，Ping F，et al.Successful treatment of crush syndrome complicated with multiple organ dysfunction syndrome using hybrid continuous renal replacement therapy.Blood Purif，2009，28（3）：175-180

　　44.Zhang L，Li Z，Fu P，et al.Hybrid renal replacement treatment in acute pulmonary edema with acute kidney injury following multiple wasp stings：a report of 3 cases.Blood Purif，2010，30（2）：106-107 连续性肾脏替代治疗